


TQ Therapeutics Email Formats
Biotechnology Research • • 1-10 Employees
Key Contacts at TQ Therapeutics
Christian Eckert
Ceo And Founder
Christian Stemberger
Cso, Co-Founder
Stefan Dreher
Chief Operations Officer And Co-Founder
Sabine Radisch
Cto And Founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
About TQ Therapeutics
TQx WILL SHIFT PARADIGMS IN CELL & GENE THERAPY. The TQx platform will transform the traditional way of producing cellular therapies, which is often slow, expensive, and hard to scale, into a very fast and highly automated process right at the patient's side. This method uses extra-corporeal gene therapy but keeps the benefits of autologous cell therapy, where patients receive treatments made from their own cells. Our TQx method makes it easier to create genetically modified immune cells (like CAR-T cells) and deliver cell therapy directly to the patient. This avoids the complicated and costly steps of centralized production. As a result, this approach unlocks the full potential of autologous cell therapies for treating conditions that were previously difficult to address, including rare autoimmune diseases and cancers.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
TQ Therapeutics has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
TQ Therapeutics has never raised funding before.
TQ Therapeutics Tech Stack
Discover the technologies and tools that power TQ Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Hosting panels
Reverse proxies
UI frameworks
Frequently asked questions
4.8
40,000 users



